CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
37.72
+2.10 (5.90%)
May 12, 2025, 1:10 PM - Market open
CRISPR Therapeutics AG Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
$74.53
Upside
+97.59%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Barclays | Barclays | Hold Maintains $56 → $42 | Hold | Maintains | $56 → $42 | +11.35% | May 9, 2025 |
Goldman Sachs | Goldman Sachs | Hold Maintains $53 → $47 | Hold | Maintains | $53 → $47 | +24.60% | May 8, 2025 |
Needham | Needham | Strong Buy Maintains $84 → $81 | Strong Buy | Maintains | $84 → $81 | +114.74% | May 7, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $84 → $82 | Strong Buy | Maintains | $84 → $82 | +117.39% | May 7, 2025 |
Needham | Needham | Strong Buy Reiterates $84 | Strong Buy | Reiterates | $84 | +122.69% | Apr 9, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Feb 19, 2025 |
Citigroup | Citigroup | Strong Buy Maintains $89 → $82 | Strong Buy | Maintains | $89 → $82 | +117.39% | Feb 18, 2025 |
Morgan Stanley | Morgan Stanley | Sell Maintains $30 → $32 | Sell | Maintains | $30 → $32 | -15.16% | Feb 14, 2025 |
Evercore ISI Group | Evercore ISI Group | Hold → Buy Upgrades $60 → $99 | Hold → Buy | Upgrades | $60 → $99 | +162.46% | Feb 14, 2025 |
Goldman Sachs | Goldman Sachs | Hold Maintains $66 → $57 | Hold | Maintains | $66 → $57 | +51.11% | Feb 13, 2025 |
JMP Securities | JMP Securities | Buy Reiterates $86 | Buy | Reiterates | $86 | +128.00% | Feb 13, 2025 |
Stifel | Stifel | Hold Maintains $53 → $49 | Hold | Maintains | $53 → $49 | +29.90% | Feb 13, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $65 | Strong Buy | Reiterates | $65 | +72.32% | Feb 13, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $94 → $84 | Strong Buy | Maintains | $94 → $84 | +122.69% | Feb 13, 2025 |
Truist Securities | Truist Securities | Strong Buy Maintains $100 → $120 | Strong Buy | Maintains | $100 → $120 | +218.13% | Feb 12, 2025 |
RBC Capital | RBC Capital | Hold Maintains $53 → $48 | Hold | Maintains | $53 → $48 | +27.25% | Feb 12, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.